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ABSTRACT
Background. Alzheimer’s disease (AD) is a neurodegenerative disease that is charac-
terized by deficits in episodic memory. It is the most common form of dementia and
affects 50–70%of patients with cognitive impairments over the age of 65. Elderly people
are particularly susceptible to malnutrition and that risk is even higher in patients with
AD. This study assessed the nutritional status of patients with AD at different stages of
AD and explored how that status correlated with cognitive, functional and behavioural
variables and caregiver overburden. The characteristics of the diet and the degree of
adherence to the Mediterranean diet were also analysed.
Methods. This was a cross-sectional study that was representative of the general
population and it was carried out in the Unit of Cognitive Disorders, Lleida, Spain.
The participants were 111 subjects with AD who were aged 65 and over and still
living at home. The subjects’ nutritional status was assessed using the Mini Nutritional
Assessment (MNA) and Controlling Nutritional Status system. The monthly food
intake was estimated using the short Food Frequency Questionnaire and adherence
to the Mediterranean diet was evaluated using the Mediterranean Diet Score. The
MiniMental State Examination (MMSE), Global Deterioration Scale, Neuropsychiatric
Inventory (NPI) and Zarit Burden Interview (ZBI) were also used.
Results. We found that 68% of the subjects presented with a risk of malnutrition
and 19% were malnourished according to the MNA scale. Patients ate a higher
quantity of meat and dairy products than recommended and fewer products from
the remaining healthier food groups. Of the 111 subjects, 73% showed low adherence
to the Mediterranean diet and 27% showed moderate adherence. There was a partial
correlation between nutritional status and the MMSE when the data were adjusted for
age and sex (r = 0,318; p= 0.001) and inverse correlations were found for functional
status (r =−0.283; p= 0.004) and the NPI (r =−0.409; p= 0.000) and ZBI scales
(r =−0.433; p= 0.000) when they were adjusted using the same variables. The ZBI
scale (OR 1.08, 95% CI [1.01–1.15]) showed an increase in the risk of malnutrition in
the multivariate analysis.
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Discussion. Alterations in nutritional status were more common during the advanced
stages of AD and were also associated with behavioural changes and caregiver overbur-
den. Low adherence to traditional healthy diets in Mediterranean countries and food
intake profiles should be considered whenmanaging patients with AD. Other countries
can use the results to examine diets in people with AD that are high in meat and dairy
and low in healthy food groups like fruit and vegetables.
Subjects Cognitive Disorders, Epidemiology, Geriatrics, Nursing, Nutrition
Keywords Alzheimer’s disease, Mediterranian diet, Nutrition Assessment, Nutritional Status,
Cognition
INTRODUCTION
Alzheimer’s Disease (AD) is a neurodegenerative disease that is characterised by episodic
memory loss and alterations in other cognitive domains, such as language, praxia and
executive functions. Patients also display a great variety of psychological and behavioural
symptoms, such as apathy, depression and hallucinations (McKhann et al., 2011). AD is
the most frequent form of dementia and it accounts for 50–70% of patients with cognitive
impairment over the age of 65 (Winblad et al., 2016). Studies have shown that the incidence
of AD increases exponentially with age, with a prevalence of between 6–8% at 65 years of
age and 30% from the age of 85 (Fratiglioni & Qiu, 2011; Prince et al., 2013).
Although its aetiology is not precisely known, amyloid accumulation is the most
frequent and specific pathological alteration of the disease and this plays a role in the
development of all the physiopathological process that are triggered during AD. However,
there are multiple factors that can promote, or enhance, the development of the disease and
these include female sex, age and all the cardiovascular risk factors, including high blood
pressure, diabetes, insulin resistance, hypercholesterolemia, obesity, smoking, physical
exercise and diet (Kivipelto et al., 2005; Beydoun, Beydoun &Wang, 2008; Peters et al., 2008;
Craft, 2009; Etgen et al., 2011; Candeias et al., 2017; Gottesman et al., 2017). Studies have
indicated that patients with AD present with weight loss years before the onset of the
disease (White, McConnell & Bales, 2004; Knopman et al., 2007; Gao et al., 2011). Once the
disease has started to develop, people with AD have problems related to buying food
and preparing meals and even remembering whether or not they have eaten. When AD
reaches the more advanced stages, patients need help to eat, because they experience
eating behaviour disorders, such as difficulties swallowing and, or, chewing (Doty, 2001;
Luchsinger & Mayeux, 2004; Shatenstein, Kergoat & Reid, 2007). All these factors may have
an impact on the patients’ nutritional status.
Even in developed societies, elderly people are particularly susceptible to the risk of
malnutrition (Saka et al., 2010) and this risk is even higher in patients with AD, where
the prevalence of malnutrition ranges between 14–41% (Cuervo et al., 2009; Roque, Salva
& Vellas, 2013; Droogsma et al., 2013). Several studies have proved that malnutrition,
weight loss and cachexia are associated with cognitive dysfunction, a decrease in an
individual’s capacity to carry out daily activities and an increase inmorbidity andmortality,
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(Guerin et al., 2005a; Droogsma, Van Asselt & De Deyn, 2015). Therefore, an appropriate
nutritional intervention is vital if the disease is to be correctly managed (Scarmeas et
al., 2009a; Scarmeas et al., 2009b). The Mediterranean diet provides key elements for the
maintenance of cerebral structures and functions, such as omega-3 fatty acids, folic acid,
carotenoids and vitamin E (Serra et al., 2003; Garcia, Berenguer & González, 2006; Giuseppe
et al., 2013). Although it varies by country and regions, the Mediterranean diet is high in
vegetables, fruits, legumes, nuts, beans, cereals, grains, fish and unsaturated fats, such as
olive oil. In contrast, it usually includes a low intake of meat and dairy foods.
However, studies have also shown that this diet is increasingly difficult to adhere to,
even in Mediterranean countries, due to social and occupational changes as people move
around and enjoy more varied cuisines. These difficulties are enhanced in patients with
AD, as they find it hard to prepare their own meals (Abellán et al., 2016).
In view of these existing issues, many questions have remained unresolved with regard
to the relationship between nutrition and cognition in AD patients. The purpose of this
study was to: (i) evaluate patients’ nutritional status at different stages of AD, (ii) evaluate
their adherence to the Mediterranean diet and (iii), correlate the links between nutritional
status and several aspects of AD, such as cognition, behavioural symptoms, functionality
and the caregivers’ burden.
MATERIALS AND METHODS
Ethical standards
This study was conducted according to the guidelines laid down in the Declaration of
Helsinki and all procedures involving human subjects were approved by the medical ethics
committee of the Hospital Universitario de Santa María in Lleida (ref number 1276). All
patients and caregivers provided written, informed consent.
Study design and population
This was an observational study that prospectively and consecutively recruited 111 subjects
who lived in their own homes and attended the Cognitive Disorders Unit at the Hospital
Universitario de Santa María in Lleida. All patient follow ups in this Unit and all diagnoses
of AD followed the criteria developed byMcKhann et al. (2011).
The patients in the study had all undergone neuropsychological evaluation and structural
neuroimaging, namely computed tomography and, or, magnetic resonance imaging, at
the discretion of the specialist in charge. The analytical protocol included a blood count
and basic biochemistry, thyroid-stimulating hormone, vitamin B12, folic acid and syphilis
serology.
Patients were included if they were 65 years or older, had been followed up in the Unit
when they were diagnosed with AD and had a Global Deterioration Scale (GDS) score of
3–6. We excluded patients who had been diagnosed with any dementia other than AD
or who had any somatic, psychiatric, or neurological disorders that might have caused
their cognitive impairment. Patients were also excluded if they had other chronic diseases
that could contribute to the alteration of nutritional status independently of AD, such
as chronic kidney disease, severe heart failure or cancer, and patients with any visual or
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auditory impairment that meant they would not be able to perform the tests included in
the study. The other exclusion criteria were patients who lived in long-term care facilities,
those who did not have anyone who could provide reliable information on their eating
habits, and those whose had mobility problems that meant that anthropometric measures
could not be taken.
Assessment instruments and data collection
A trained nurse carried out the structured interviews for data collection from January 2014
to January 2016. The epidemiological data including age, gender, education, family history
and a medical history of hypertension, type 1 and 2 diabetes, hypercholesterolemia and
depression. We also reviewed their smoking and alcohol habits. Habitual smoking was
defined as 10 or more cigarettes per day and the patient was at risk of alcoholism if their
alcohol intake was more than 20–30 grams per day. The time it took for their symptoms to
evolve was also recorded.
Cognitive functions were examined using the Mini Mental State Examination (MMSE)
(Folstein, Folstein & Mchugh, 1975) and functionality was evaluated using the Global
Deterioration Scale (GDS), which is broken down into seven different stages: 1–2 are
considered to be the pre-dementia stages and 3–7 cover the continuum frommild cognitive
impairment to dementia (Reisberg et al., 1982). Patients who were at stage seven were
excluded, as they rarely attended hospital outpatient clinics.
Neuropsychiatric symptoms were evaluated using the Neuropsychiatric Inventory
(NPI) (Cummings et al., 1994; Vilalta et al., 1999), which is the most widely used scale for
determining the frequency and intensity of neuropsychiatric disorders in AD patients. It
consists of 12 items: delusions, hallucinations, agitation/aggression, dysphoria, anxiety,
euphoria, apathy, disinhibition, irritability/lability, aberrant motor activity, night-time
behavioural disturbances and appetite/eating disorders. The total value is obtained by
multiplying the frequency by the severity. Frequency is assessed using a scale of 0–4 where
zero is absent, one is occasionally, namely less than once per week, two is often, which is
about once per week, three is frequently, which is several times per week and four is very
frequently, namely daily or continuously. Severity is measured on a 1–3 scale, where one
is mild, two is moderate and three is severe.. The caregiver is asked whether the patient’s
behaviour has changed since the onset of dementia and, if so, whether the altered behaviour
was present during the month before the NPI was used. The total score is the sum of all
the subscale scores.
Finally, the burden of caregivers was evaluated using the Zarit Burden Interview (ZBI)
(Martín et al., 1996), which is a well-known caregivers’ self-report measure that has been
used in many dementia studies. The revised version contains 22 statements that the
caregiver is asked to assess by using a five-point scale, with response options ranging from
one to never to five for nearly always. Higher total scores indicate higher caregiver burdens.
All patients were examined to obtain the following anthropometric parameters: height,
weight, body mass index (BMI), waist circumference, mid-upper arm circumference, calf
circumference and triceps skin-fold measurements.
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The patients’ nutritional status was assessed using the Mini Nutritional Assessment
(MNA) scale (Guigoz, Vellas & Garry, 1994), the short Food Frequency Questionnaire
(FFQ) (Trinidad et al., 2008) and the CONtrolling NUTritional status (CONUT) system
(Ulíbarri et al., 2005).
The MNA consists of 18 questions divided into four nutritional areas. The four
anthropometric measurements are BMI, mid-upper arm circumference, calf circumference
and weight loss and the global assessment comprises six questions related to lifestyle,
medication and physical and mental state. The dietary assessment comprises six questions
related to daily food intake, intake problems and a subjective assessment and there is
also a question on the patient’s self-perception of sufficient intake and a question on
self-perception of their general health. The maximum score is 30: a score of less than 17 is
consideredmalnutrition, a score of 17–23.5 is considered at risk ofmalnutrition and scoring
24 or higher is considered a satisfactory nutritional status (Guigoz, Vellas & Garry, 1994).
The short FFQ consists of 45 items that asks the patient or caregiver for details of the
weekly or monthly intake of certain foods (Trinidad et al., 2008).
The CONUT System of Nutritional Control is used to alert medical staff that a
patient has malnutrition and it consists of three parameters: two biochemical parameters
(serum albumin and cholesterol) and an immunological parameter (total lymphocytes).
The maximum score is 12, with 0–4 indicating low undernourishment, 5–8 moderate
undernourishment and 9–12 severe undernourishment (Ulíbarri et al., 2005).
Adherence to traditional Spanish diet was measured using the Mediterranean Diet Score
(MDS), which assesses whether it is low (scores 0–3), moderate (scores 4–5) or high (scores
6–8). The score covers the daily intake, in grams, of different food groups: vegetables,
fruit-nuts, pulses, fish, alcohol, cereal, meat and dairy products. A score of one indicates
that the intake is higher than recommended and a score of zero indicates that intake is lower
than recommended. High scores for meat and dairy products were regarded as harmful,
but they were regarded good for other food groups. (Trichopoulou et al., 1995; Hu et al.,
2002; Trichopoulou et al., 2003). We also took into account whether the patient ate alone
or with others, whether they had chewing difficulties, whether they prepared their own
meals and the patient’s and caregiver’s levels of income. These aspects were not included in
the validated scales, but scientific literature has shown them to be relevant to the patients’
nutritional status (Grundman et al., 1996; Riviere et al., 1999). These additional assessments
were recorded during a semi-structured interview and the data were dichotomized as yes
or no.
The Biomedical Ethics Committee of the Lleida country approved the study and all
patients and caregivers provided written informed consent.
Statistical analysis
The statistical data analyses were performed using SPSS for Windows, version 16, (SPSS
Inc, Chicago, IL, USA). The results of the different variables were expressed as their
means and standard deviations for the quantitative variables and as percentages for the
qualitative variables. The statistical significance of the differences between the quantitative
and qualitative variables were assessed using analysis of variance (ANOVA) and Pearson’s
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Table 1 Socio-demographic, cognitive and behavioural characteristics and caregiver burden of the
study population, and nutritional status according toMNA scale.
Variable Normal
(n= 15)
Risk of malnutrition
(n= 75)
Malnutrition
(n= 21)
p value
Age 79.0± 5.6 77.7± 6.4 81.0± 6.1 0.96
Women (%) 53.3% 62.7% 76.2% 0.34
HTA 73.3% 58.9% 50.0% 0.38
DM 13.3% 25.1% 40.0% 0.03
Hypercol 46.7% 47.9% 45.0% 0.97
Depression 26.7% 31.9% 57.1% 0.07
BMI 27.2± 3.8 27.4± 4.1 24.6± 3.3 0.01
Waist 98.4± 11.2 98.9± 10.7 95.3± 9.8 0.39
Mid-upper arm 28.9± 6.2 29.6± 3.3 28.2± 3.6 0.18
Skin fold 13.5± 5.3 16.2± 6.0 18.3± 5.0 0.19
Albumin 4.2± 0.06 4.1± 0.09 4.1± 0.44 0.81
Total cholesterol 203.2± 49.6 198.0± 38.7 199.5± 39.2 0.59
LDL 114.2± 21.4 118.5± 31.9 126.7± 28.9 0.18
MMSE 17.1± 6.3 19.8± 5.2 14.5± 7.0 0.03
GDS 4.0± 1.0 3.9± 0.8 4.5± 1.2 0.12
Zarit 37.2± 15.8 48.4± 16.2 50.3± 12.9 0.05
NPI 9± 8.5 11.5± 11.3 18.8± 21.9 0.06
Notes.
TSH, Thyroid-stimulating hormone; HTA, Arterial hypertension; DM, Diabetes mellitus types 1 and type 2; Hypercol,
Hypercholesterolemia; BMI, Body mass index; LDL, Low density lLipoproteins; MMSE, Mini Mental State Examination;
GDS, Global Deterioration Scale; NPI, Neuropsychiatric Inventory.
chi-square test was used to compare the percentages of the variables. Spearman’s bivariate
correlation, adjusted by sex and age, was used to investigate the existence of correlations
between the clinical variables. Multivariate logistic regression models were built for
predicting malnutrition and the risk of malnutrition. Both models were built with variable
selections by backwards stepwise procedures based on likelihood ratios. Values of less than
0.05 were considered statistically significant.
RESULTS
We studied 111 patients (63.4% women) with an average age of 78.5 ± 6.4 years. With
regard to their family history, 38.4% presented with first degree AD and all experienced
onset when they were more than 65 years of age. In terms of pathological background,
the most prevalent risk factor was arterial hypertension (58.7%), followed by dyslipidemia
(46.8%) and type 1 and 2 diabetes mellitus (19.3%) (Table 1). We noted that 45% of the
patients were overweight, only 3.6% had been habitual smokers and 27.9% had consumed
levels of alcohol that put them at risk for alcoholism.
The percentage of patients at risk of malnutrition was 67.6%, while 18.9% presented
with malnutrition according to the MNA scale (Table 2). No differences were observed
between the sexes.
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Table 2 Nutritional characteristics of the study population according to theMNA and CONUT scales.
MNA Men
(%)
Women
(%)
Total
(%)
CONUT Lowmalnutrition alert
(%)
Normal nutritional status 7 (17.5) 8 (11.3) 15 (13.5) 2 (6.7)
Risk of malnutrition 28 (70.0) 47 (66.2) 75 (67.6) 22 (73.3)
Malnutrition 5 (12.5) 16 (22.5) 21 (18.9) 6 (20.0)
Total 40 (36.0) 71 (64.0) 111 (100) 30 (100)
Table 3 Food intake evaluation of the study population, according to the FFQ scale.
% less than recommended average %more than recommended average
Men (%) Women (%) Total (%) Men (%) Women (%) Total (%)
Vegetables 36 (90.0) 59 (83.1) 95 (85.7) 4 (10.0) 12 (16.9) 16 (14.4)
Fruit and nuts 37 (92.5) 53 (74.6) 90 (81.3) 3 (7.5) 18 (25.4) 21 (18.9)
Dairy products 8 (20.0) 9 (12.7) 17 (16.1) 32 (80.0) 62 (87.3) 94 (84.7)
Cereals 39 (97.5) 60 (84.5) 99 (89.3) 1 (2.5) 11 (15.5) 12 (10.8)
Pulses 40 (100) 71 (100) 111 (100) 0 (0) 0 (0) 0 (0)
Meat 30 (75.0) 29 (40.8) 59 (53.6) 10 (25.0) 42 (59.2) 52 (46.8)
Fish 35 (87.5) 71 (100) 106 (95.5) 5 (12.5) 0 (0) 5 (4.5)
Alcohol 24 (60.0) 56 (78.9) 80 (72.3) 16 (40.0) 15 (21.1) 31 (27.9)
A sub sample of 30 subjects was also assessed using the CONUT scale. All subjects
received a low malnutrition alert, although 73.3% of the total sample were at risk of
malnutrition according to the MNA assessment. We stopped using it the CONUT scale
because of its reduced ability to classify patients.
Despite the high scores for the patients’ malnutrition risk, the BMI analysis revealed
that 45% were overweight and 18.9% were obese, meaning that 63.9% of subjects analysed
were above the BMI for normal weight. Another highlight is 69.3% of patients with risk of
malnutrition were obese or overweight, so it seems that BMI is not a good indicator in this
population.
The short FFQ questionnaire was used build up a more detailed picture of the intake of
the different food groups. As a general rule, 85.6% of patients consumed a lower quantity of
vegetables than recommended and this was also the case for other good groups: 81.1% for
fruit and nuts, 100% for pulses, 89.2% for cereals and 95.5% for fish. In contrast, almost
half of the patients (46.8%) ate more meat than recommended and 84.7% consumed
more dairy products (Trichopoulou et al., 1995) (Table 3). No significant differences were
observed between the sexes or the different stages of the disease.
When we assessed adherence to the Mediterranean diet using the MDS, we found that
73% of subjects demonstrated low adherence and 27% had moderate adherence (Table 4).
It is worth noting that no patient met the criteria for good adherence to the Mediterranean
diet and there were no significant differences between adherence to Mediterranean diet
and the nutritional status, according to the MNA (p= 0.62).
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Table 4 Adherence to the Mediterranean diet, according to theMDS
Adherence to DiMed Men, n= 40 (%) Women, n= 71 (%) Total n= 111 (%)
Diet score (0–3) = Low 32 (80.0) 49 (69.0) 81 (73.0)
Diet score (4–5) =Moderate 8 (20.0) 22 (31.0) 30 (27.0)
Diet score (6–8) =High 0 (0.0) 0 (0.0) 0 (0.0)
Table 5 GDS, MMSE, NPI, Zarit andMNA correlations in patients with Alzheimer’s sdisease.
MNA
Screening Total
Spearman’s correlation (r) p value Spearman’s correlation (r) p value
MMSE 0.283 0.000 .318 0.001
GDS −0.298 0.001 −.283 0.004
NPI −0.306 0.003 −.409 0.000
Zarit −0.306 0.004 −.433 0.000
Notes.
MMSE, Mini Mental State Examination; GDS, Global Deterioration Scale; NPI, Neuropsychiatric Inventory.
Further data analysis showed a possible correlation between the patients’ nutritional
status and their cognitive performance, functionality and degree of behavioural alterations.
A partial correlation was found when the nutritional status was assessed with the MMSE
(r = 0,318; p= 0.001), and adjusted for age and sex, and an inverse correlation was found
when the functional situation was assessed with the GDS (r =−0.283; p= 0.004) on the
same basis. In addition, a correlation was found with the NPI (r =−0.409; p= 0.000)
and with the ZBI scale (r =−0.433; p= 0.000) (Table 5), adjusted for age and sex. In the
multivariate analysis, the NPI score (r =−0.249; p= 0.047) (OR 0.99; 95% CI [0.92–1.07])
and the ZBI scale (r =−0.357; p= 0.004) (OR 1.08; 95% CI [1.01–1.15]) showed a higher
risk of malnutrition controlled by the scores in the MMSE and the GDS.
Finally, patients’ eating habits that were not reflected in the scales we used, and those
that were of potential interest, were assessed but none of these variables were significantly
associated to a worse nutritional status (p> 0.05). These were whether the patient ate alone,
needed help to eat, were able to prepare their own food, whether they had any chewing
difficulties and the income levels of the patient and caregiver (Table 6).
DISCUSSION
This study evaluated the nutritional status of a population of patients aged over 65, who
were diagnosed with AD and living at home. Since recruitment was consecutive, and
the unit where it took place was the only one in the health region, the sample obtained
was representative of the region studied. It can be inferred from the socio demographic
characteristics and the prevalence of cardiovascular risk factors that this population was
similar to that of Spanish and European studies on populations diagnosed with AD (De
Pedro-Cuesta et al., 2009;Warchol-Celinska et al., 2015; Niu et al., 2017).
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Table 6 Correlation between eating difficulties and the caregiver’s income with the patients’ risk of
malnutrition.
MNA
Screening Total
Pearson correlation (r) p value Pearson correlation (r) p value
Eats in company 0.159 0.171 −0.059 0.171
Needs help to eat 0.225 0.051 −0.213 0.065
Prepares meals −0.046 0.696 0.052 0.654
Has chewing difficulties 0.011 0.925 −0.045 0.704
Patient’s income −0.091 0.448 −0.146 0.220
Caregiver’s income −0.262 0.058 0.130 0.352
When we used the MNA scale, the high prevalence of malnutrition (18.9%) and risk
of malnutrition (67.6%) was notable, as it was even higher than expected for people of
the same age with no cognitive impairment. The prevalence for the latter group has been
reported to range from 15.2% and 50% according to different studies (Cuervo et al., 2008;
Zekry et al., 2008; Jürschik et al., 2009; Unanue et al., 2009; De Luis et al., 2011; Nykänen et
al., 2013). In similar studies carried out in the Mediterranean region, namely Italy and
France, the prevalence of malnutrition and risk of malnutrition were 42.8% and 28%
respectively, using the MNA scale (Ousset et al., 2008; Spaccavento et al., 2009). In a study
carried out by Roque, Salva & Vellas (2013) on a population with the same characteristics
as our study, 40.8% faced a risk of malnutrition, but only 4.8% actually presented with
malnutrition. Finally, a literature review carried out byGuigoz (2006) on subjects diagnosed
with AD found that the prevalence of the risk of malnutrition ranged between 19% and
36% and the actual presence of malnutrition ranged between 0% and 6% (Andrieu et al.,
2001; Rivière et al., 2001; Nourhashemi et al., 2005; Gillette-Guyonnet et al., 2013).
The causes of the high prevalence of malnutrition may be secondary to multiple aspects,
such as difficulties preparing meals and eating a varied diet, having swallowing problems
or poor food absorption. We considered other parameters that were not included in the
traditional scales that could be related to the degree of undernourishment, such as eating
alone, needing help to eat or prepare meals and the patient’s and caregiver’s economic
situation. However, the results did not show any statistically significant associations.
Several epidemiological studies have demonstrated that being overweight or obese
in middle age may increase the risk of AD (Whitmer et al., 2005; Whitmer et al., 2007;
Gustafson et al., 2012). By contrast, other studies have related losing weight to the
development of cognitive impairment (Gillette-Guyonnet et al., 2007; Shatenstein, Kergoat
& Reid, 2007). The anthropometric variables, including the BMI analysis, were no use in
our study when it came to evaluating the patient’s nutritional status. The average BMI of the
patients at risk of malnutrition (27.4 ± 4.1) indicated that a high number of patients were
overweight. This could lead us to believe that the subjects in our study were undernourished
due to an unhealthy diet and not because they didn’t eat enough food. This finding could
be supported by the low ratio of MDS observed in our patients. Similar results were found
by Roque, Salva & Vellas (2013) in their study, where the risk of malnutrition was not
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supported by other tools like the subject’s BMI. In line with our results, that study observed
that the presence of malnutrition could coexist with a normal BMI or even a BMI that was
higher than normal.
Regarding the use of other scales, we could not find studies that assessed the usefulness
of the CONUT scale in populations diagnosed with AD, but our results showed that the
MNA scale was more useful in evaluating nutritional status than the CONUT scale in this
type of population.
It is notable from our results that a worse nutritional status correlated with worse
cognitive, functional and behavioural performance and with greater caregiver overburden,
when these factors were assessed using the ZBI scale. A possible explanation for this is
that patients with more advanced stages of AD habitually present with higher risks of
behavioural alterations, which can be associated with greater caregiver overburden. Some
authors have associated the risk of malnutrition, both in cognitively healthy elderly people
and those with dementia, to factors such as the presence of behavioural symptoms, namely
delirium, hallucinations, apathy and depression (Guerin et al., 2005b; Spaccavento et al.,
2009; Isaia et al., 2011) and worse scores with the MMSE (Nykänen et al., 2013; Roque,
Salva & Vellas, 2013). This would help to explain the association between worse nutritional
status and greater caregiver overburden in our sample, as observed in the literature (Roepke
et al., 2011; Legido et al., 2013). For this reason, it is important to provide caregivers with
support and advice on changes associated with AD, to help them deal with those changes
in the best possible way and to reduce the levels of stress and overburden and ensure the
person they care for has a better nutritional status.
Another result worth highlighting is that in the advanced stages of AD the patient’s
nutritional status worsened, as found in previous studies (Botella & Ferrero, 2004;
Luchsinger & Mayeux, 2004; Vieira, Figueiredo & Garcia, 2015).
Finally, with regard to the Mediterranean diet, Catalonia is considered one of the
most important regions in the world for this diet, but a very high percentage of patients
in our sample (73%) showed low adherence to this diet. In general, they had a higher
intake of meat and dairy products than recommended and a lower intake of fruit and
vegetables, especially pulses. However, these results were similar to those published by
other recent studies on Spanish populations, including the study carried out by Abellán
et al. (2016), who also observed low adherence to the Mediterranean diet by their general
study population. This suggests that while other countries in the world are trying to
adopt the Mediterranean diet as their reference diet, Spain is abandoning it. A progressive
detachment from the Mediterranean diet pattern by the Spanish population, and an
unbalanced diet, was observed in a study carried out by Ruiz et al. (2015), although low
adherence to Mediterranean diet was not correlated with body weight. This trend was also
observed in the present study.
Our study provides important data, since several studies have demonstrated that the
Mediterranean diet has been associated with greater cognitive performance and greater
cerebral volume (Titova et al., 2013). Gardener et al. (2012) studied elderly people and
observed that subjects diagnosed with AD had a lower score when they followed a
Mediterranean diet, followed by subjects with mild cognitive impairment. In contrast,
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subjects without cognitive impairment presented the highest scores for adherence to
the Mediterranean diet. This study also observed a correlation between the baseline
Mediterranean diet score and the change in the MMSE score between the baseline
assessment and the 18-month follow up of healthy subjects (Gardener et al., 2012). Several
meta-analyses have suggested that greater adherence to a Mediterranean diet have been
associated with lower cognitive deterioration, dementia and AD (Van de Rest et al., 2015)
and even lowered the risk of progression of mild cognitive impairment into AD (Scarmeas
et al., 2009a; Scarmeas et al., 2009b; Singh et al., 2014). Sofi et al. (2010) observed that a two
percentage point increase in adherence to theMediterranean diet score decreased the risk of
the incidence of neurodegenerative diseases (risk ratio 0.87; 95%CI 0.81, 0.94).Psaltopoulou
et al. (2013) observed that high adherence to a Mediterranean diet was associated with a
reduced risk of cognitive impairment and depression, respectively. However, other studies
have observed significant differences between cognitive performance and adherence to a
Mediterranean diet (Chan, Chan &Woo, 2013; Samieri et al., 2013a; Samieri et al., 2013b),
or demonstrated that this diet can improve cognitive performance in patients with no
cognitive impairment. However, it remains unclear whether it can lower or postpone
the risk of AD onset (Féart et al., 2009; Ngandu et al., 2015). In addition, a systematic
review by Petersson & Philippou (2016) concluded that adherence to a Mediterranean
diet was associated with improved cognitive performance, according to the findings of
epidemiological studies. These findings underline the importance of good adherence to a
Mediterranean diet. On the other hand, as we observed, no patient in our study showed
high adherence to a Mediterranean diet.
The strengths of our study include the fact that it was carried out on patients who were
being regularly followed up by an AD referral unit in our health region and therefore
there was a high degree of diagnostic certainty. Another strength was that patients were
assessed using different psychometric tests and nutritional scales, which allowed us to
build up a global picture of the person’s general status and their eating habits. The
study also had limitations because of it design. For example, the exclusion criteria included
institutionalised patients and patients living at home with no reliable source of information
about their eating habits. Patients who were at advanced stages of the disease and could
not attend the unit were also excluded. Therefore, this study could not provide conclusions
about the nutritional status of patients who had advanced stages of AD and limited support
at home or about associated pathologies that carried the potential risk of anorexia, which
may have lead to underestimating the prevalence of malnutrition found in people with AD.
CONCLUSIONS
Our findings led us to conclude that there was a high prevalence of malnutrition and risk
of malnutrition, and low adherence to a Mediterranean diet, in the patients diagnosed
with AD in this study. In addition to behavioural alterations and caregiver’s overburden,
the progression of AD was associated with worse nutritional status and correlated with
cognition, daily activities and neuropsychiatric symptoms.
For all these reasons, we believe that it should be routine clinical practice for memory
units to carry out appropriate evaluations of the nutritional status of patients diagnosed
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with AD. This would then enable clinical staff to provide support to ensure that their
patients have a healthy nutritional status.
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